Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

Is Citalopram recalled?

Not under an active recall. Citalopram was recalled 8 times in the past — all now closed. Most recent: Jan 26, 2022.

Most common reason: Chemical / undeclared (3 of these recalls)

Recalls are matched by product description. A recall usually affects specific lots, not every package of Citalopram. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed. Checked against openFDA on Oct 10, 2026.

Citalopram recalls on record

none so far in 2026; 8 on record, newest first
Class II · Moderate risk

CITALOPRAM Tablets

CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.

Terminated Temperature excursion Cardinal Healthcare D-0173-2024
Class III · Low risk

Citalopram Oral Solution

Failed Impurities/Degradation Specifications; high out of specification results obtained at the 9 month stability timepoint

Terminated Impurity / degradation PAI Holdings, LLC. dba Pharmaceutical Associates Inc NDC 0121-1696-40 D-0015-2021
Class II · Moderate risk

Citalopram Hydrobromide active pharmaceutical ingredient packaged…

Penicillin Cross Contamination: All lots of all products repackaged between 01/05/12 through 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Terminated Cross-contamination Attix Pharmaceuticals D-591-2015
Class II · Moderate risk

CITALOPRAM Tablet

Labeling:Label Mixup; CITALOPRAM Tablet, 10 mg may be potentially mislabeled as OXYBUTYNIN CHLORIDE, Tablet, 5 mg, NDC 00603497521, Pedigree: AD52778_61, EXP: 5/20/2014; COENZYME Q-10, Capsule, 30 mg, NDC 00904501546, Pedigree: W002814, EXP: 6/7/2014.

Terminated Labeling / mix-up Aidapak Services, LLC D-630-2014
Class II · Moderate risk

Citalopram tablets USP

Chemical Contamination: The product is being recalled due to complaints reporting a strong garlic odor or strong chemical smell.

Terminated Chemical / undeclared Dr. Reddy's Laboratories, Inc. NDC 55111-344-30 D-180-2013
Class II · Moderate risk

Citalopram tablets USP

Chemical Contamination: The product is being recalled due to complaints reporting a strong garlic odor or strong chemical smell.

Terminated Chemical / undeclared Dr. Reddy's Laboratories, Inc. NDC 55111-343-30 D-179-2013
Class II · Moderate risk

Citalopram tablets USP

Chemical Contamination: The product is being recalled due to complaints reporting a strong garlic odor or strong chemical smell.

Terminated Chemical / undeclared Dr. Reddy's Laboratories, Inc. NDC 55111-342-30 D-178-2013